- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x TAU: 2-AMINOETHANESULFONIC ACID(Non-covalent)
TAU.6: 8 residues within 4Å:- Chain A: F.87, R.89, S.153
- Chain B: F.123, S.182, F.183, Y.226, T.228
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:F.183, A:S.153
- Salt bridges: A:R.89
TAU.13: 8 residues within 4Å:- Chain A: F.123, S.182, F.183, Y.226, T.228
- Chain E: F.87, R.89, S.153
3 PLIP interactions:2 interactions with chain E, 1 interactions with chain A- Hydrogen bonds: E:S.153, A:F.183
- Salt bridges: E:R.89
TAU.26: 8 residues within 4Å:- Chain B: F.87, R.89, S.153
- Chain C: F.123, S.182, F.183, Y.226, T.228
3 PLIP interactions:1 interactions with chain C, 2 interactions with chain B- Hydrogen bonds: C:F.183, B:S.153
- Salt bridges: B:R.89
TAU.39: 8 residues within 4Å:- Chain C: F.87, R.89, S.153
- Chain D: F.123, S.182, F.183, Y.226, T.228
3 PLIP interactions:1 interactions with chain D, 2 interactions with chain C- Hydrogen bonds: D:F.183, C:S.153
- Salt bridges: C:R.89
TAU.52: 8 residues within 4Å:- Chain D: F.87, R.89, S.153
- Chain E: F.123, S.182, F.183, Y.226, T.228
3 PLIP interactions:2 interactions with chain D, 1 interactions with chain E- Hydrogen bonds: D:S.153, E:F.183
- Salt bridges: D:R.89
- 60 x UNL: UNKNOWN LIGAND(Non-functional Binders)
UNL.7: 2 residues within 4Å:- Chain B: V.313
- Ligands: UNL.21
Ligand excluded by PLIPUNL.8: 2 residues within 4Å:- Chain A: I.253
- Ligands: UNL.9
Ligand excluded by PLIPUNL.9: 4 residues within 4Å:- Chain A: N.426, I.431, K.434
- Ligands: UNL.8
Ligand excluded by PLIPUNL.10: 3 residues within 4Å:- Chain A: V.264, W.267
- Ligands: UNL.24
Ligand excluded by PLIPUNL.11: 1 residues within 4Å:- Chain A: W.267
Ligand excluded by PLIPUNL.12: 1 residues within 4Å:- Ligands: UNL.25
Ligand excluded by PLIPUNL.14: 5 residues within 4Å:- Chain A: I.309, F.425, F.428, Y.433
- Ligands: UNL.15
Ligand excluded by PLIPUNL.15: 3 residues within 4Å:- Chain A: V.304
- Ligands: UNL.14, UNL.65
Ligand excluded by PLIPUNL.16: 1 residues within 4Å:- Chain A: L.420
Ligand excluded by PLIPUNL.17: 3 residues within 4Å:- Chain A: L.316, F.418
- Ligands: UNL.18
Ligand excluded by PLIPUNL.18: 3 residues within 4Å:- Chain A: I.410
- Ligands: UNL.17, UNL.68
Ligand excluded by PLIPUNL.19: 1 residues within 4Å:- Ligands: UNL.70
Ligand excluded by PLIPUNL.20: 5 residues within 4Å:- Chain B: I.309, F.425, F.428, Y.433
- Ligands: UNL.21
Ligand excluded by PLIPUNL.21: 3 residues within 4Å:- Chain B: V.304
- Ligands: UNL.7, UNL.20
Ligand excluded by PLIPUNL.22: 1 residues within 4Å:- Chain B: L.420
Ligand excluded by PLIPUNL.23: 3 residues within 4Å:- Chain B: L.316, F.418
- Ligands: UNL.24
Ligand excluded by PLIPUNL.24: 3 residues within 4Å:- Chain B: I.410
- Ligands: UNL.10, UNL.23
Ligand excluded by PLIPUNL.25: 1 residues within 4Å:- Ligands: UNL.12
Ligand excluded by PLIPUNL.27: 2 residues within 4Å:- Chain C: V.313
- Ligands: UNL.34
Ligand excluded by PLIPUNL.28: 2 residues within 4Å:- Chain B: I.253
- Ligands: UNL.29
Ligand excluded by PLIPUNL.29: 4 residues within 4Å:- Chain B: N.426, I.431, K.434
- Ligands: UNL.28
Ligand excluded by PLIPUNL.30: 3 residues within 4Å:- Chain B: V.264, W.267
- Ligands: UNL.37
Ligand excluded by PLIPUNL.31: 1 residues within 4Å:- Chain B: W.267
Ligand excluded by PLIPUNL.32: 1 residues within 4Å:- Ligands: UNL.38
Ligand excluded by PLIPUNL.33: 5 residues within 4Å:- Chain C: I.309, F.425, F.428, Y.433
- Ligands: UNL.34
Ligand excluded by PLIPUNL.34: 3 residues within 4Å:- Chain C: V.304
- Ligands: UNL.27, UNL.33
Ligand excluded by PLIPUNL.35: 1 residues within 4Å:- Chain C: L.420
Ligand excluded by PLIPUNL.36: 3 residues within 4Å:- Chain C: L.316, F.418
- Ligands: UNL.37
Ligand excluded by PLIPUNL.37: 3 residues within 4Å:- Chain C: I.410
- Ligands: UNL.30, UNL.36
Ligand excluded by PLIPUNL.38: 1 residues within 4Å:- Ligands: UNL.32
Ligand excluded by PLIPUNL.40: 2 residues within 4Å:- Chain D: V.313
- Ligands: UNL.47
Ligand excluded by PLIPUNL.41: 2 residues within 4Å:- Chain C: I.253
- Ligands: UNL.42
Ligand excluded by PLIPUNL.42: 4 residues within 4Å:- Chain C: N.426, I.431, K.434
- Ligands: UNL.41
Ligand excluded by PLIPUNL.43: 3 residues within 4Å:- Chain C: V.264, W.267
- Ligands: UNL.50
Ligand excluded by PLIPUNL.44: 1 residues within 4Å:- Chain C: W.267
Ligand excluded by PLIPUNL.45: 1 residues within 4Å:- Ligands: UNL.51
Ligand excluded by PLIPUNL.46: 5 residues within 4Å:- Chain D: I.309, F.425, F.428, Y.433
- Ligands: UNL.47
Ligand excluded by PLIPUNL.47: 3 residues within 4Å:- Chain D: V.304
- Ligands: UNL.40, UNL.46
Ligand excluded by PLIPUNL.48: 1 residues within 4Å:- Chain D: L.420
Ligand excluded by PLIPUNL.49: 3 residues within 4Å:- Chain D: L.316, F.418
- Ligands: UNL.50
Ligand excluded by PLIPUNL.50: 3 residues within 4Å:- Chain D: I.410
- Ligands: UNL.43, UNL.49
Ligand excluded by PLIPUNL.51: 1 residues within 4Å:- Ligands: UNL.45
Ligand excluded by PLIPUNL.53: 2 residues within 4Å:- Chain E: V.313
- Ligands: UNL.60
Ligand excluded by PLIPUNL.54: 2 residues within 4Å:- Chain D: I.253
- Ligands: UNL.55
Ligand excluded by PLIPUNL.55: 4 residues within 4Å:- Chain D: N.426, I.431, K.434
- Ligands: UNL.54
Ligand excluded by PLIPUNL.56: 3 residues within 4Å:- Chain D: V.264, W.267
- Ligands: UNL.63
Ligand excluded by PLIPUNL.57: 1 residues within 4Å:- Chain D: W.267
Ligand excluded by PLIPUNL.58: 1 residues within 4Å:- Ligands: UNL.64
Ligand excluded by PLIPUNL.59: 5 residues within 4Å:- Chain E: I.309, F.425, F.428, Y.433
- Ligands: UNL.60
Ligand excluded by PLIPUNL.60: 3 residues within 4Å:- Chain E: V.304
- Ligands: UNL.53, UNL.59
Ligand excluded by PLIPUNL.61: 1 residues within 4Å:- Chain E: L.420
Ligand excluded by PLIPUNL.62: 3 residues within 4Å:- Chain E: L.316, F.418
- Ligands: UNL.63
Ligand excluded by PLIPUNL.63: 3 residues within 4Å:- Chain E: I.410
- Ligands: UNL.56, UNL.62
Ligand excluded by PLIPUNL.64: 1 residues within 4Å:- Ligands: UNL.58
Ligand excluded by PLIPUNL.65: 2 residues within 4Å:- Chain A: V.313
- Ligands: UNL.15
Ligand excluded by PLIPUNL.66: 2 residues within 4Å:- Chain E: I.253
- Ligands: UNL.67
Ligand excluded by PLIPUNL.67: 4 residues within 4Å:- Chain E: N.426, I.431, K.434
- Ligands: UNL.66
Ligand excluded by PLIPUNL.68: 3 residues within 4Å:- Chain E: V.264, W.267
- Ligands: UNL.18
Ligand excluded by PLIPUNL.69: 1 residues within 4Å:- Chain E: W.267
Ligand excluded by PLIPUNL.70: 1 residues within 4Å:- Ligands: UNL.19
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yu, J. et al., Mechanism of gating and partial agonist action in the glycine receptor. Cell (2021)
- Release Date
- 2021-01-06
- Peptides
- Glycine receptor subunit alphaZ1: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x TAU: 2-AMINOETHANESULFONIC ACID(Non-covalent)
- 60 x UNL: UNKNOWN LIGAND(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yu, J. et al., Mechanism of gating and partial agonist action in the glycine receptor. Cell (2021)
- Release Date
- 2021-01-06
- Peptides
- Glycine receptor subunit alphaZ1: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.